Search Results1-20 of  25

  • 1 / 2
  • 永山 績夫 ID: 9000000636715

    大鵬薬品 (2001 from CiNii)

    Articles in CiNii:2

    • テガフールからの5-フルオロウラシル生成におけるヒト肝P450およびチミジンホスホリラーゼの関与 (2001)
    • TAS-102経口投与におけるヒトFTD代謝の予測 (2001)
  • 永山 績夫 ID: 9000001973949

    大鵬薬品工業株式会社 薬物動態研究所 (2008 from CiNii)

    Articles in CiNii:2

    • 赤血球分配法を用いた血漿蛋白結合率測定法の評価 (2007)
    • 第3回ショートコース開催趣意 (2008)
  • 永山 績夫 ID: 9000005897144

    大鵬薬品・育薬研究所 (2005 from CiNii)

    Articles in CiNii:1

    • TaqMan Low density array の精度検証とヒト大腸癌への応用(第105回日本外科学会定期学術集会) (2005)
  • 永山 績夫 ID: 9000013964469

    大鵬薬品工業代謝分析研 (2002 from CiNii)

    Articles in CiNii:1

    • クリアランスモデルに基づいた TAS-102 経口投与時の FTD 体内動態の予測 : ラット, サルからヒトへ (2002)
  • 永山 績夫 ID: 9000015170602

    Articles in CiNii:1

    • 臨床におけるバイオマーカーとPK/PD (特集1 承認申請を踏まえたPK/PD情報の活用と当局対応) (2006)
  • 永山 績夫 ID: 9000020423737

    大鵬薬品工業 (株) (1995 from CiNii)

    Articles in CiNii:1

    • Drug mutual relationship between antiherpes agents and anticancerous metabolic antagonists.Acyclovir and FU system drugs. (1995)
  • 永山 績夫 ID: 9000391915220

    大鵬薬品工業 (2003 from CiNii)

    Articles in CiNii:1

    • 日本人一般母集団に見出された薬物動態関連遺伝子のSNPによるcytochrome P450活性への影響 (2003)
  • NAGAYAMA Sekio ID: 9000000608519

    Taiho Pharmaceutical Co., Ltd. (1996 from CiNii)

    Articles in CiNii:2

    • Pharmacokinetics of S-1-Two way biochemical modulation for enhancing 5-FU delivery into tumor and reducing GI toxicities (1996)
    • 抗ヘルペス剤と抗癌性代謝拮抗物質との薬物相互関係について : アシクロビルとFU系薬剤 (1995)
  • NAGAYAMA Sekio ID: 9000002977697

    大鵬薬品工業株式会社代謝分析研究所 (2003 from CiNii)

    Articles in CiNii:15

    • MECHANISM OF LETHAL TOXICITY EXERTED BY SIMULTANEOUS ADMINISTRATION OF THE NEW ANTIVIRAL, SORIVUDINE, AND THE ANTITUMOR AGENT, TEGAFUR (1995)
    • ソリブジンから代謝的に生成する(E)-5-(2-ブロモビニル)ウラシルによるラット肝ジヒドロピリミジンデヒドロゲナ-ゼの不可逆的不活性化のメカニズム (1995)
    • ラットにおけるテガフールとソリブジンの薬物相互作用による毒性発現(1) (1995)
  • NAGAYAMA Sekio ID: 9000252831234

    Tokushima Research Center, Taiho Pharmaceutical Co., Ltd (1997 from CiNii)

    Articles in CiNii:1

    • INACTIVATION MECHANISM OF HUMAN DIHYDROPYRIMIDINE DEHY DROGENASE BY 5-(2'-BROMOVINYL)URACIL, A METABOLITE OF THE ANTIVIRAL, SORIVUDINE (1997)
  • NAGAYAMA Sekio ID: 9000253261951

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(5): Transfer to Fetus and Milk of Components of S-1 in Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253261957

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Dispositon of Components of New Anti-cancer Drug S-1(4): Distribution of Components of S-1 after Repeated Administration to Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253261964

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(3): Absorption, Excretion of Components of S-1 and Effects on Hepatic Drug Metabolizing Enzyme System after Repeated Administration of S-1 to Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253261972

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(2): Distribution of Components of S-1 after Single Administration to Rats and Protein Binding. (1997)
  • NAGAYAMA Sekio ID: 9000253261980

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1(1): Absorption and Excretion of Components of S-1 after Single Administration to Rats. (1997)
  • NAGAYAMA Sekio ID: 9000253262013

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (8): Species Differences, Dose Proportionality. (1997)
  • NAGAYAMA Sekio ID: 9000253262020

    Pharmacokinetics Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd. (1997 from CiNii)

    Articles in CiNii:1

    • Disposition of Components of New Anti-cancer Drug S-1 (6): Metabolism of Components of S-1 in Rats. (1997)
  • NAGAYAMA Sekio ID: 9000383085090

    Department of Biochemistry, Research Laboratory, Taiho Pharmaceutical Co. (1980 from CiNii)

    Articles in CiNii:1

    • STUDIES ON THE METABOLISM OF 1-(2-TETRAHYDROFURYL)-5-FLUORO-URACIL AND URACIL CO-ADMINISTERED ORALLY TO TUMOR-BEARING RATS (1980)
  • Nagayama Sekio ID: 9000283796183

    Pharmacokinetics Research Laboratory, Taiho Pharmaceutical Co., Ltd (2004 from CiNii)

    Articles in CiNii:1

    • INTESTINAL PERMEABILITY AND METABOLISM IN RAT, DOG AND MONKEY DETERMINED USING DIFFUSION CHAMBER METHOD (2004)
  • Nagayama Sekio ID: 9000283796536

    Pharmacokinetoics Research Laboratory, Taiho Pharmaceutical Co.,Ltd (2004 from CiNii)

    Articles in CiNii:1

    • IDENTIFICATION OF A NEW METABOLITE OF TAS-108 IN TISSUE BY LC/MS/MS APPROACH USING STABLE ISOTOPE LABELED TAS-108 AS A MARKER (2004)
  • 1 / 2
Page Top